# OP0166 EFFICACY AND SAFETY OF TWO YEARS OF TREATMENT WITH ANTI-IL-5/R THERAPIES FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/op0166-efficacy-and-safety-of-two-years-of-treatment-with-anti-il-5-r-therapies/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Peter A. Merkel,Parameswaran Nair,Nader Khalidi,B. Terrier,B. Hellmich,Arnaud Bourdin,David Jayne,Daniel J. Jackson,Florence Roufosse,Christian Pagnoux,U. Specks,Lena Börjesson Sjö,C.N. Ho,Maria Jison,Christopher McCrae,S. Necander,Eva Rodríguez‐Suárez,A. Shavit,C. Walton,M.E. Wechsler |
| Citations | 0 |
| DOI | 10.1016/j.ard.2025.05.179 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1016/j.ard.2025.05.179 |
| OpenAlex ID | https://openalex.org/W4411395643 |
| Type | conference-abstract |
| Year | 2025 |

## Paper authors

- [C.N. Ho](https://scholariq.org/researchers/c-n-ho/)

## Paper journal

- [Annals of the Rheumatic Diseases](https://scholariq.org/journals/annals-of-the-rheumatic-diseases/)

## Paper primary topic

- [Eosinophilic Esophagitis](https://scholariq.org/topics/eosinophilic-esophagitis/)

## Paper topics

- [Eosinophilic Esophagitis](https://scholariq.org/topics/eosinophilic-esophagitis/)
- [Eosinophilic Disorders and Syndromes](https://scholariq.org/topics/eosinophilic-disorders-and-syndromes/)
- [IL-33, ST2, and ILC Pathways](https://scholariq.org/topics/il-33-st2-and-ilc-pathways/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.